title: Alternative splicing programs in prostate cancer.
abstract: Prostate cancer (PCa) remains one of the most frequent causes of death for cancer in the male population. Although the initial antiandrogenic therapies are efficacious, PCa often evolves into a hormone-resistant, incurable disease. The genetic and phenotypic heterogeneity of this type of cancer renders its diagnosis and cure particularly challenging. Mounting evidence indicates that alternative splicing, the process that allows production of multiple mRNA variants from each gene, contributes to the heterogeneity of the disease. Key genes for the biology of normal and neoplastic prostate cells, such as those encoding for the androgen receptor and cyclin D1, are alternatively spliced to yield protein isoforms with different or even opposing functions. This review illustrates some examples of genes whose alternative splicing regulation is relevant to PCa biology and discusses the possibility to exploit alternative splicing regulation as a novel tool for prognosis, diagnosis, and therapeutic approaches to PCa.
authors: Department of Biomedicine and Prevention, University of Rome "Tor Vergata," 00133 Rome, Italy ; Laboratory of Neuroembryology, Fondazione Santa Lucia IRCCS, 00143 Rome, Italy.
authors: Claudio
authors: C
authors: Sette
references: Hum Mol Genet. 2008 Jan 1;17(1):52-70
references: 17913700
references: J Cell Biochem. 2008 Jul 1;104(4):1491-9
references: 18348186
references: Cancer Res. 2005 Jul 1;65(13):5761-8
references: 15994951
references: Clin Cancer Res. 2009 Sep 1;15(17):5338-49
references: 19706803
references: J Biol Chem. 2005 Jun 17;280(24):22641-50
references: 15837790
references: Nature. 2010 Dec 2;468(7324):664-8
references: 20881964
references: Nature. 2013 Jun 13;498(7453):236-40
references: 23685454
references: Endocr Relat Cancer. 2011 Sep 20;18(5):R183-96
references: 21778211
references: Nucleic Acids Res. 2012 Feb;40(3):1021-32
references: 21984414
references: Adv Exp Med Biol. 2010;693:54-66
references: 21189685
references: Endocr Relat Cancer. 2011 Jul 01;18(4):R91-R102
references: 21565971
references: Cell. 2010 Aug 20;142(4):625-36
references: 20705336
references: Mol Cell Biol. 2009 Dec;29(24):6438-48
references: 19805512
references: J Clin Invest. 2008 Aug;118(8):2711-21
references: 18596922
references: J Steroid Biochem Mol Biol. 2007 Nov-Dec;107(3-5):131-9
references: 17659869
references: Cancer Res. 2011 Mar 15;71(6):2108-17
references: 21248069
references: Clin Cancer Res. 2009 Aug 1;15(15):4792-8
references: 19638458
references: Mol Cell Biol. 2008 Oct;28(19):5924-36
references: 18663000
references: Cancer Res. 2009 Jan 1;69(1):16-22
references: 19117982
references: Nat Struct Mol Biol. 2007 Mar;14(3):185-93
references: 17310252
references: Nat Struct Mol Biol. 2012 Jan 15;19(2):220-8
references: 22245967
references: Proc Natl Acad Sci U S A. 2011 Oct 25;108(43):17779-84
references: 22006329
references: Cell. 1993 Aug 27;74(4):597-608
references: 8358789
references: Nucleic Acids Res. 2013 Jan 7;41(1):554-64
references: 23143267
references: Am J Pathol. 2012 Sep;181(3):1007-16
references: 22819534
references: Mayo Clin Proc. 2010 Jan;85(1):77-86
references: 20042563
references: Chem Biol. 2007 Dec;14(12):1386-92
references: 18096507
references: Science. 2001 Dec 21;294(5551):2563-6
references: 11752579
references: J Biol Chem. 2010 Sep 10;285(37):28893-901
references: 20610388
references: Nature. 2002 Dec 12;420(6916):691-5
references: 12478298
references: Mol Cell Biol. 2002 Aug;22(16):5698-707
references: 12138182
references: Carcinogenesis. 2008 Dec;29(12):2279-88
references: 18809972
references: Endocrinology. 2007 Mar;148(3):1359-66
references: 17158207
references: PLoS One. 2013;8(3):e49721
references: 23472063
references: Cancer Res. 2009 Mar 15;69(6):2305-13
references: 19244107
references: Cancer Res. 2005 Feb 15;65(4):1213-22
references: 15735005
references: J Biol Chem. 2009 Aug 7;284(32):21458-67
references: 19520842
references: Cell Cycle. 2010 Oct 1;9(19):3874-9
references: 20890126
references: Mol Cell. 2012 Aug 10;47(3):422-33
references: 22727668
references: Pharmacol Ther. 2012 Dec;136(3):283-94
references: 22909788
references: Cancer Res. 2010 Jan 1;70(1):229-39
references: 20028857
references: PLoS One. 2011;6(12):e29088
references: 22194994
references: Oncogene. 2006 Mar 13;25(11):1620-8
references: 16550162
references: Nature. 2011 Oct 05;478(7367):123-6
references: 21979052
references: EMBO J. 2010 Apr 7;29(7):1235-47
references: 20186123
references: Genes Dev. 2010 Nov 1;24(21):2343-64
references: 21041405
references: J Cell Biol. 2007 Mar 26;176(7):929-39
references: 17371836
references: Cancer Res. 2003 Nov 1;63(21):7056-61
references: 14612495
references: J Biol Chem. 2002 Dec 20;277(51):49374-82
references: 12381725
references: Cancer Res. 2008 Oct 1;68(19):7938-46
references: 18829551
references: Nucleic Acids Res. 2010 Dec;38(22):8348-56
references: 20719743
references: Mol Cell Biol. 2007 Jul;27(13):4863-75
references: 17452459
references: Cell Div. 2006 Jul 24;1:15
references: 16863592
references: Clin Cancer Res. 2008 Aug 1;14(15):4719-25
references: 18676740
references: Nat Rev Drug Discov. 2012 Nov;11(11):847-59
references: 23123942
references: J Clin Invest. 2013 Jan;123(1):493-508
references: 23257359
references: Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14134-9
references: 20679199
references: Cancer Res. 2008 Jul 1;68(13):5469-77
references: 18593950
references: FASEB J. 2006 Aug;20(10):1680-2
references: 16790528
references: Am J Pathol. 2004 Apr;164(4):1243-51
references: 15039213
references: Mol Cell Biol. 2012 Jul;32(14):2880-93
references: 22615491
references: Oncogene. 2013 Jun 6;32(23):2848-57
references: 22797067
references: Cell. 2009 May 15;137(4):708-20
references: 19450518
references: Cancer Res. 2013 Jan 15;73(2):483-9
references: 23117885
references: Oncogene. 2007 Jun 28;26(30):4372-82
references: 17237817
references: Int J Cell Biol. 2013;2013:151839
references: 24069033
references: Cancer Res. 2008 Oct 15;68(20):8516-24
references: 18922926
references: J Biol Chem. 2001 May 11;276(19):16411-7
references: 11278482
references: Nat Rev Cancer. 2001 Oct;1(1):34-45
references: 11900250
references: J Pathol. 2008 May;215(1):67-77
references: 18273831
references: BMC Bioinformatics. 2006 Apr 11;7:202
references: 16608523
references: Curr Cancer Drug Targets. 2009 Mar;9(2):237-49
references: 19275762
references: J Biol Chem. 2002 Apr 12;277(15):12587-95
references: 11801602
references: Nat Rev Genet. 2011 Sep 16;12(10):715-29
references: 21921927
references: J Biol Chem. 2008 Aug 1;283(31):21315-24
references: 18534987
references: Cancer Res. 2010 May 15;70(10):3975-84
references: 20460515